Acquiring Company
Resonant Clinical Solutions
Acquired Company
Creapharm
Description
Resonant Clinical Solutions has acquired Creapharm Bioservices to enhance its Biorepository capabilities in Europe. This acquisition aims to support complex clinical programs, particularly in cell and gene therapies. With this addition, Resonant strengthens its global offerings and ability to manage sensitive biological materials. The partnership addresses the industry's growing demand for specialized storage solutions.
Don't miss Resonant Clinical Solutions's next move
Get an email the moment Resonant Clinical Solutions makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
M&A Insights
Based on deal dataFrequently asked
Who acquired Creapharm?
Creapharm was acquired by Resonant Clinical Solutions, based in Leesburg. The deal was reported on September 3, 2026. Resonant Clinical Solutions is a global provider of outsourced clinical trial solutions. Resonant Clinical Solutions is privately held and operates in Biotechnology.
When did Resonant Clinical Solutions acquire Creapharm?
Resonant Clinical Solutions's acquisition of Creapharm was reported on September 3, 2026. Resonant Clinical Solutions has acquired Creapharm Bioservices to enhance its Biorepository capabilities in Europe. This acquisition aims to support complex clinical programs, particularly in cell and gene therapies. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Creapharm do?
With decades of experience in global clinical trial supply management, Creapharm supports Pharma and Biotech key players with customized solutions. It is privately held, operating in Manufacturing, and is based in France.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.